Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

Objectives To determine the incidence of any and referable diabetic retinopathy in people with type 2 diabetes mellitus attending an annual screening service for retinopathy and whose first screening episode indicated no evidence of retinopathy. Design Retrospective four year analysis. Setting Screenings at the community based Diabetic Retinopathy Screening Service for Wales, United Kingdom. Participants 57 199 people with type 2 diabetes mellitus, who were diagnosed at age 30 years or older and who had no evidence of diabetic retinopathy at their first screening event between 2005 and 2009. 49 763 (87%) had at least one further screening event within the study period and were included in the analysis. Main outcome measures Annual incidence and cumulative incidence after four years of any and referable diabetic retinopathy. Relations between available putative risk factors and the onset and progression of retinopathy. Results Cumulative incidence of any and referable retinopathy at four years was 360.27 and 11.64 per 1000 people, respectively. From the first to fourth year, the annual incidence of any retinopathy fell from 124.94 to 66.59 per 1000 people, compared with referable retinopathy, which increased slightly from 2.02 to 3.54 per 1000 people. Incidence of referable retinopathy was independently associated with known duration of diabetes, age at diagnosis, and use of insulin treatment. For participants needing insulin treatment with a duration of diabetes of 10 years or more, cumulative incidence of referable retinopathy at one and four years was 9.61 and 30.99 per 1000 people, respectively. Conclusions Our analysis supports the extension of the screening interval for people with type 2 diabetes mellitus beyond the currently recommended 12 months, with the possible exception of those with diabetes duration of 10 years or more and on insulin treatment.

[1]  D. Spiegelhalter,et al.  Screening for Treatable Diabetic Retinopathy: a Comparison of Different Methods , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[2]  M. Bachmann,et al.  Trends in yield and effects of screening intervals during 17 years of a large UK community‐based diabetic retinopathy screening programme , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[3]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[4]  C. D. Atkins Re: Colorectal cancer screening: sifting through the evidence. , 1999, Journal of the National Cancer Institute.

[5]  Simon P Harding,et al.  Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study , 2003, The Lancet.

[6]  V. Basevi Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[7]  A. Giani,et al.  UKPDS 50 : risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis , 2022 .

[8]  K. Khunti,et al.  Effectiveness of screening and monitoring tests for diabetic retinopathy – a systematic review , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[9]  R Greenwood,et al.  Grading and disease management in national screening for diabetic retinopathy in England and Wales , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[10]  C. Forsblom,et al.  Decline in the Cumulative Incidence of Severe Diabetic Retinopathy in Patients With Type 1 Diabetes , 2011, Diabetes Care.

[11]  N. Chaturvedi,et al.  The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner‐city district of North London: a quality of care study , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[12]  Comparison of the effectiveness of detecting diabetic eye disease: diabetic retinal photography versus ophthalmic consultation. , 2004, Singapore medical journal.

[13]  M. C. Leske,et al.  Nine-year incidence of diabetic retinopathy in the Barbados Eye Studies. , 2006, Archives of ophthalmology.

[14]  J Clowes,et al.  Preservation of sight in diabetes: developing a national risk reduction programme , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[15]  C. Thivolet,et al.  Screening of diabetic retinopathy: effect of field number and mydriasis on sensitivity and specificity of digital fundus photography. , 2008, Diabetes & metabolism.

[16]  Graham P. Leese,et al.  A national retinal screening programme for diabetes in Scotland , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[17]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. , 1987, Ophthalmology.

[18]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. , 1989, Archives of ophthalmology.

[19]  R. Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. , 1995, Ophthalmology.

[20]  R. Hayward,et al.  Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. , 2000, JAMA.

[21]  D. Owens,et al.  Non-mydriatic Polaroid photography in screening for diabetic retinopathy: evaluation in a clinical setting , 1988, British medical journal.

[22]  R. Blamey,et al.  The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research. , 2002, European journal of cancer.

[23]  M. C. Leske,et al.  Incidence of diabetic retinopathy in the Barbados Eye Studies. , 2003, Ophthalmology.

[24]  F L Ferris,et al.  Photocoagulation for diabetic macular edema. , 1987, Archives of ophthalmology.

[25]  E. Agardh,et al.  Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without Retinopathy , 2011, Diabetes Care.

[26]  B. Levin Colorectal cancer screening: sifting through the evidence. , 1999, Journal of the National Cancer Institute.

[27]  J. Cuzick,et al.  Benefit of cervical screening at different ages: evidence from the UK audit of screening histories , 2003, British Journal of Cancer.

[28]  Jochanan Benbassat,et al.  Reliability of screening methods for diabetic retinopathy , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[29]  E. Stefánsson,et al.  Biennial eye screening in patients with diabetes without retinopathy: 10-year experience , 2007, British Journal of Ophthalmology.

[30]  C. Bunce,et al.  Causes of blind certifications in England and Wales: April 1999–March 2000 , 2008, Eye.

[31]  Marilyn James,et al.  Cost effectiveness analysis of screening for sight threatening diabetic eye disease , 2000, BMJ : British Medical Journal.

[32]  Ronald Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. , 2009, Ophthalmology.

[33]  Erick Suárez,et al.  Are adults diagnosed with diabetes achieving the American Diabetes Association clinical practice recommendations? , 2012, Puerto Rico health sciences journal.

[34]  Stephen J. Aldington,et al.  UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.

[35]  S. Harding,et al.  Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[36]  J. J. Wang,et al.  Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study , 2007, Eye.

[37]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[38]  H. Akaike A new look at the statistical model identification , 1974 .

[39]  H P Friedman,et al.  Searching for evidence of altered gene expression: a comment on statistical analysis of microarray data. , 1999, Journal of the National Cancer Institute.

[40]  D R Owens,et al.  Screening for diabetic retinopathy by general practitioners: ophthalmoscopy or retinal photography as 35 mm colour transparencies? , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[41]  P. Scanlon,et al.  Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy , 2003, The British journal of ophthalmology.

[42]  V. Gil-Guillén,et al.  Screening for sight threatening diabetic retinopathy using non‐mydriatic retinal camera in a primary care setting: to dilate or not to dilate? , 2009, International journal of clinical practice.